Home › Funds › Uniplan Investment Counsel, Inc. › IRMD
Uniplan Investment Counsel, Inc. position in IRMD
IRADIMED CORP · Health Care
Uniplan Investment Counsel, Inc. reported holding 75,724 shares of IRMD (IRADIMED CORP) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.64% of its reported portfolio and ranking #40 among its reported holdings. Uniplan Investment Counsel, Inc. has disclosed IRMD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Uniplan Investment Counsel, Inc.'s IRMD position evolved
Uniplan Investment Counsel, Inc. first disclosed a stake in IRMD in Q4 2024 at 32,540 shares (US$1.8M). The position peaked in Q3 2026 at 75,724 shares, worth US$6.5M. Across 8 filings, Uniplan Investment Counsel, Inc. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 75,724 shares valued at US$6.5M — an increase of 9,322 shares quarter over quarter.. Notable position changes include a 50% increase in Q1 2025 (shares rose 14% over the following quarter), a 65% increase in Q2 2025 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 32.54K | $1.79M | New |
| Q1 2025 | 48.73K | $2.56M | Add |
| Q2 2025 | 80.35K | $4.80M | Add |
| Q3 2025 | 77.31K | $5.50M | Reduce |
| Q4 2025 | 65.69K | $6.39M | Reduce |
| Q1 2026 | 62.14K | $5.98M | Reduce |
| Q2 2026 | 66.40K | $6.35M | Add |
| Q3 2026 | 75.72K | $6.53M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRMD and 13F data
IRMD (IRADIMED CORP) is a Health Care company. 46 other funds we track also report a position in IRMD — the largest reported positions include Bridge City Capital, LLC (US$8.4M), Nine Ten Capital Management LLC (US$8.3M), SHAKER INVESTMENTS LLC/OH (US$7.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRMD
- Bridge City Capital, LLC 96.97K sh · $8.36M · Q3 2026
- Nine Ten Capital Management LLC 96.33K sh · $8.31M · Q3 2026
- SHAKER INVESTMENTS LLC/OH 91.31K sh · $7.87M · Q3 2026
- Davidson Capital Management Inc. 63.02K sh · $5.43M · Q3 2026
More on Uniplan Investment Counsel, Inc.
FAQ
How long has Uniplan Investment Counsel, Inc. held IRMD?
Uniplan Investment Counsel, Inc. has disclosed IRMD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Uniplan Investment Counsel, Inc.'s current position in IRMD?
As of Q3 2026, Uniplan Investment Counsel, Inc. holds 75.72K shares of IRMD (IRADIMED CORP), valued at $6.53M, representing 0.64% of its reported portfolio and ranking #40.
Has Uniplan Investment Counsel, Inc. been buying or selling IRMD?
In the latest 13F filing (Q3 2026), Uniplan Investment Counsel, Inc. increased its position in IRMD. The position peaked in Q3 2026 at 75.72K shares.
Which other funds hold IRMD?
Other major institutional holders of IRMD include Bridge City Capital, LLC, Nine Ten Capital Management LLC, SHAKER INVESTMENTS LLC/OH, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.